Opsonic and Antibody Responses to Pneumococcal Polysaccharide in Rheumatoid Arthritis Patients Receiving Golimumab Plus Methotrexate. - Wikidata - awgldk - TriplyDB

Opsonic and Antibody Responses to Pneumococcal Polysaccharide in Rheumatoid Arthritis Patients Receiving Golimumab Plus Methotrexate.

Opsonic and Antibody Responses to Pneumococcal Polysaccharide in Rheumatoid Arthritis Patients Receiving Golimumab Plus Methotrexate.

http://www.wikidata.org/entity/Q37624175

about

Opsonic and Antibody Responses to Pneumococcal Polysaccharide in Rheumatoid Arthritis Patients Receiving Golimumab Plus Methotrexate.

http://www.wikidata.org/entity/Q37624175

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2015

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Opsonic and Antibody Responses ...... g Golimumab Plus Methotrexate.

@en

Opsonic and Antibody Responses ...... g Golimumab Plus Methotrexate.

@nl

type

label

Opsonic and Antibody Responses ...... g Golimumab Plus Methotrexate.

@en

Opsonic and Antibody Responses ...... g Golimumab Plus Methotrexate.

@nl

prefLabel

Opsonic and Antibody Responses ...... g Golimumab Plus Methotrexate.

@en

Opsonic and Antibody Responses ...... g Golimumab Plus Methotrexate.

@nl

P1433

Q37624175-8F88FAE6-6F4D-4DFD-BC34-2579C9CADCF5

P1476

Q37624175-79A860C6-3C17-49E6-B3F0-30646445FB67

P2093

Q37624175-0281CEF7-D0B4-416C-A9FE-2CF7D4269CF8

Q37624175-09A82376-7245-46E8-BE94-4E875048EFD6

Q37624175-0DEA3350-10CE-4FC4-8E91-BFCF1000D990

Q37624175-13C3B745-AC22-45FC-B392-CB73FB371DD9

Q37624175-1871BA5E-155A-4580-9515-276CB3A2291A

Q37624175-23C9991B-46C8-4D96-933D-FC30139C9ECD

Q37624175-246E7085-AD03-4F7D-AFBD-6121C50F1305

Q37624175-41295F89-219E-4B87-862B-BDA417A97F10

Q37624175-4267AF5B-0F39-412B-85E2-A04714C176B1

Q37624175-48E6C0EA-463E-4951-8E13-B8647BCD02C7

P2860

Q37624175-1047D52D-9156-4465-AE72-A49CF0B53037

Q37624175-10B6AE46-E755-4EBD-A13B-F91F21C68364

Q37624175-1B07A1A7-7E77-4FB0-ADC6-F0C5F485D8FF

Q37624175-22A59FDA-6C15-42BC-8BEE-F0C9D0C868B5

Q37624175-38428C60-57E1-424D-A4CC-98454CCF4659

Q37624175-3EEB948C-6EEF-41EE-B8F1-E5D135E24BF3

Q37624175-56FB755E-A39F-4ECC-80B5-542DEAFA730C

Q37624175-581C3344-7B08-429A-B495-BF54C9619E61

Q37624175-60211FD8-9D32-4677-8933-A32B625618C2

Q37624175-718B7496-333A-4207-A730-A8FCC41EC74E

P304

Q37624175-959F792C-3B2C-4CB4-BFEF-DE916827DB69

P31

Q37624175-75BE12F5-F3CF-4CEB-B1C6-E08A610779C4

P356

Q37624175-FF062386-E09A-4636-9CC1-0342EEFA019D

P407

Q37624175-3F21CB86-F02D-492A-A84C-3180A46CE592

P433

Q37624175-755B3933-8593-40F3-B8D8-2D150CB4B24D

P478

Q37624175-4C9F0A5A-D2C0-4B4F-8E6D-FC085C5D1C7D

P577

Q37624175-2D1EFD88-FC1F-4029-B6F6-4C09C284BCBB

P698

Q37624175-98253D83-5468-4422-9182-39B1090845CA

P921

Q37624175-40917A0D-AFA1-411B-89D1-561C202BC683

P932

Q37624175-65332A78-A12E-454D-94BE-DD833DC8C3D7

P356

MD.0000000000002184

P1433

P1476

Opsonic and Antibody Responses ...... g Golimumab Plus Methotrexate.

@en

P2093

Akinori Matsumori

http://www.w3.org/2001/XMLSchema#string

Eiichi Suematsu

http://www.w3.org/2001/XMLSchema#string

Fuminori Hirano

http://www.w3.org/2001/XMLSchema#string

Haruko Ideguchi

http://www.w3.org/2001/XMLSchema#string

Hideaki Nagai

http://www.w3.org/2001/XMLSchema#string

Hideko Kozuru

http://www.w3.org/2001/XMLSchema#string

Hiroshi Furukawa

http://www.w3.org/2001/XMLSchema#string

Hiroshi Tsutani

http://www.w3.org/2001/XMLSchema#string

Kazunori Oishi

http://www.w3.org/2001/XMLSchema#string

Kenji Kawakami

http://www.w3.org/2001/XMLSchema#string

P2860

Correlation of molecular characteristics, isotype, and in vitro functional activity of human antipneumococcal monoclonal antibodies.

Older adults have a low capacity to opsonize pneumococci due to low IgM antibody response to pneumococcal vaccinations

Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study.

Infectious complications of biologic treatments of rheumatoid arthritis.

Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides

Protective immunity of pneumococcal glycoconjugates.

Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus.

Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor.

Persistence of antibody response 1.5 years after vaccination using 7-valent pneumococcal conjugate vaccine in patients with arthritis treated with different antirheumatic drugs.

Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy.

P304

e2184

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000002184

http://www.w3.org/2001/XMLSchema#string

P407

P433

52

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26717361

http://www.w3.org/2001/XMLSchema#string

P921

polysaccharides

P932

5291602

http://www.w3.org/2001/XMLSchema#string